IgAN/FSGS Monitoring Program | Timing TBD
This educational material is at the concept stage and is not currently in development. Support is not currently being sought for this activity. If the concept advances, independent expert faculty will develop the material; any future supporters will have no role in faculty selection, content development, conclusions, or dissemination.
Status: Concept stage. Support is not currently being sought.
Practical frameworks for monitoring cadence tradeoffs (frequency, patient burden, cost, actionable yield) and evaluation decision points in IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS).
Covers: what monitoring changes should trigger additional testing, closer follow-up, or escalation of evaluation, and what patterns typically do not warrant escalation. This material does not provide treatment recommendations.
Concept-stage material
Development timing TBD